Flexion Therapeutics Inc 3 SEC Filings

Filed On	Filing
23 Nov 2021	Form 3: Newtyn Management, Llc, 10% owner Holds 5,900,000 shares of Common Stock, par value $0.001 per share
12 Jul 2021	Form 3: Koppikar Utpal, Director No securities owned
06 Jul 2021	Form 3: Andrews William T., Chief Medical Officer No securities owned
03 Jun 2021	Form 3: Driscoll Frederick W, Chief Financial Officer Holds 2,680 shares of Common Stock
06 Jan 2021	Form 3: Muzikant Adam, Chief Business Officer Holds 77,460 shares of Common Stock
20 Aug 2020	Form 3: Kwo Elizabeth, Director No securities owned
13 Mar 2020	Form 3: Layman Melissa, Chief Commercial Officer No securities owned
22 Jan 2019	Form 3: Willwerth Christina, Chief Strategy Officer Holds 22,419 shares of Common Stock
07 May 2018	Form 3: Arkowitz David, Chief Financial Officer Holds 10,250 shares of Common Stock
29 Dec 2017	Form 3: Wentworth Kerry, Chief Regulatory Officer Holds 5,077 shares of Common Stock
15 Dec 2017	Form 3: Kelley Scott, Chief Medical Officer Holds 5,701 shares of Common Stock
26 Jun 2017	Form 3: Levine Mark S., SVP & General Counsel Holds 0 shares of No securities are beneficially owned.
05 Apr 2017	Form 3: Deniz Yamo, Chief Medical Officer Holds 0 shares of No securities are beneficially owned
14 Sep 2016	Form 3: Stejbach Mark, Director No securities owned
06 Mar 2015	Form 3: Canute Scott A, Director No securities owned
24 Jul 2014	Form 3: Mahatme Sandesh, Director Holds 0 shares of No securities are beneficially owned.
13 Jun 2014	Form 3: Merrifield C Ann, Director Holds 0 shares of No securities are beneficially owned.
11 Feb 2014	Form 3: Novo A/S, 10% owner
11 Feb 2014	Form 3: Versant Venture Capital III, L.p., 10% owner and 2 others Holds 73,367 shares of Common Stock
11 Feb 2014	Form 3: Tordjman Rafael, Director

Comments